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ABSTRACT
This paper presents a delay-dependent parameter-varying
control design approach to address the automated blood pres-
sure regulation problem in the critical patient resuscitation using
closed-loop administration of vasopressors. The mean arterial
pressure (MAP) response of a patient subject to the intravenous
vasoactive drug treatment is modeled as a linear parameter-
varying (LPV) model, where varying model parameters and
varying time-delay are considered as scheduling parameters of
the system. Parameter-dependent Lyapunov-Krasovskii function-
als are used to design an output-feedback dynamic controller to
satisfy the closed-loop stability and reference MAP tracking re-
quirements. The synthesis conditions are formulated in terms of
Linear Matrix Inequalities (LMIs) that characterize the induced
L2-norm performance specification of the closed-loop system.
The main objectives of the proposed control method in the pres-
ence of limitations posed by the time-varying model parameters
and the large time-varying delay are to track the MAP reference
command and maintain the blood pressure within the permissi-
ble range of commanded set-point, avoid undesirable overshoot
and slow response, and to provide a smooth drug injection. Fi-
nally, to evaluate the performance of the proposed LPV blood
pressure regulation approach, closed-loop simulations are con-
ducted and the results confirm the effectiveness of the proposed
control method against various simulated scenarios.
∗Shahin Tasoujian is a Ph.D. candidate in Mechanical Engineering at the Uni-
versity of Houston, Houston, TX 77204, U.S.A. e-mail: stasoujian@uh.edu.
K. Grigoriadis and M. Franchek are also with the University of Houston.
INTRODUCTION
The cardiovascular system can be seen as a hydraulic system
that circulates blood as its working fluid and it is characterized in
terms of pressure and flow variability. The mean arterial blood
pressure (MAP) regulation of a patient to a desired target value is
essential in many clinical and operative procedures in emergency
resuscitation. For this purpose, two types of vasoactive drugs
are being used to attain a target MAP in emergency resuscita-
tion: (1) vasodilator drug to decrease the MAP to a target value,
like sodium nitroprusside (SNP) which reduces the tension in the
blood vessel walls [1], (2) vasopressor drugs to increase the MAP
to a target value, like phenylephrine (PHP) which stimulates the
depressed cardiovascular system causing vasoconstriction [2].
Typically, MAP control and regulation procedures in clin-
ical care are carried out manually using a syringe or infusion
pump with a manual titration by the medical personnel. In these
cases, drug delivery and adjustment may not be precisely man-
aged, which can lead to undesirable or potentially fatal conse-
quences, such as, increased cardiac workload and cardiac arrest.
Moreover, manual drug administration is a time-consuming and
labor-intensive task and often is challenged by poor and slug-
gish performance. Further, inaccurate operator monitoring can
lead to under- or over-resuscitation with potentially dangerous
outcomes [3]. Accordingly, the automation of vasoactive drug
infusion via feedback control has been proposed as a potential
remedy to tackle the mentioned challenges of manual drug ad-
ministration.
Automated administration and accurate dosing of the intra-
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venous drug is still a challenging problem mostly due to the phar-
macological response variability of patients. There are consider-
able intra-patient and inter-patient variations in the physiologi-
cal MAP response to the drug infusion [4]. Moreover, the MAP
response has a large varying time-delay, which poses significant
limitations to the control design process. Therefore, the designed
control system should be robust against the complex physiologi-
cal variations and disturbances and also be able to adapt to vary-
ing patient response and large varying time-delay.
Time delay and especially large varying time delay presence
considerably complicates the control design procedure and in-
troduces instability and performance deterioration to the feed-
back system [5]. Stability analysis and control of time-delay
systems has been the subject of research in recent decades and is
classified into two general directions; namely, delay-independent
and delay-dependent approaches [6]. The delay-independent sta-
bilization criteria are based on conditions that are independent
of the size of the delay and the controller is designed regard-
less of the time delay magnitude, which leads to more conser-
vative results especially for cases with small time delays (e.g.
see [7]). On the other hand, the delay-dependent approaches re-
sult in less conservative analysis and guarantee the stability and
the prescribed performance of the system by considering all the
delays smaller than a certain determined upper bound. In re-
cent years, there have been considerable efforts to investigate the
stability of time-delay systems using delay-dependent stabiliza-
tion criteria (e.g. see [8–10]). Delay-dependent approaches typi-
cally utilize Lyapunov-Krasovskii functionals [11] or Lyapunov-
Razumnikhin functions [12] for the stability analysis and control
synthesis.
The main challenge associated with the MAP regulation
problem stems from the physiological and pharmacological vari-
ations of the considered system as well as its large varying
time-delay, that restrict the application of conventional and time-
invariant control techniques. Robust control methods treat the
variations in the plant dynamics as uncertainties and employ
time-invariant methods which leads to considerably conservative
results [13,14]. Early gain-scheduling control design approaches
were based on interpolation, and despite their time-varying na-
ture which adjusts for the system variations, they fail to pro-
vide any guarantee for asymptotic stability and/or performance
of the time-varying closed-loop system. In this regard, the ne-
cessity to design gain-scheduled controllers with guaranteed sta-
bility and performance with less conservative results has led to
the advent of linear parameter varying (LPV) gain-scheduling
synthesis [15].
LPV systems encompass linear systems whose dynamics de-
pend on time-varying parameters known as scheduling param-
eters. For the present case study, in order to utilize the pro-
posed output-feedback LPV control framework, an LPV time-
delay system formulation is developed to describe the patient’s
MAP response to vasoactive drugs, where the system is a func-
tion of observable scheduling parameters. Stability analysis and
control of LPV systems without time delay has been investi-
gated in the literature [16]. Time-delayed LPV systems where
the time-varying delay is a function of the scheduling parame-
ter are ubiquitous in engineering and the analysis and the con-
trol synthesis of those has been an interesting research topic in
the past decade. One simple but conservative approach in deal-
ing with time-delayed systems is using the Pade´ approximation
to transform the infinite-dimensional delay problem into a finite-
dimensional non-minimum phase (NMP) system, followed by an
LPV control design for a non-delay system [17, 18]. A common
direct approach in analyzing LPV systems with time delay is to
transfer the delay appearing in the input to the state. Such a sys-
tem is called LPV state-delayed systems and has been addressed
widely in the literature [17, 19]. In most of the control design
methods for time-delayed LPV systems, Lyapunov-Krasovskii
functionals are considered (see, e.g. [19]). In these studies, the
delay variation rate is not taken into account, which resulted in
conservative results.
In the present paper, we utilize parameter-dependent
Lyapunov-Krasovskii functionals to examine the stability and the
tracking performance of the closed-loop system, which leads to a
delay-dependent synthesis method that can handle arbitrary pa-
rameter variations. Accordingly, an LPV output-feedback con-
troller is designed to track a desired MAP reference and mini-
mize the effect of disturbances. For control validation purposes,
collected animal experiment data and a non-linear patient sim-
ulation model are utilized to capture the varying physiological
characteristics of a patient’s MAP response [17]. The proposed
approach is evaluated in computer simulations and compared to
the results of a conventional fixed gain proportional integral (PI)
controller which has been validated experimentally (see [20]).
The notation to be used in the paper is standard and as fol-
lows: R denotes the set of real numbers, R+ is the set of non-
negative real numbers, Rn and Rk×m are used to denote the set
of real vectors of dimension n and the set of real k×m matrices,
respectively. M  0 shows the positive definiteness of the matrix
M and the transpose of a real matrix M is shown as MT . Also,
Sn and Sn++ denote the set of real symmetric and real symmetric
positive definite n×n matrices, respectively. In a symmetric ma-
trix, the asterisk ? in the (i, j) element denotes transpose of ( j, i)
element. C (J, K) denotes the set of continuous functions from a
set J to a set K.
The outline of the paper is as follows. Section 3 introduces
a simplified mathematical representation of the studied MAP re-
sponse dynamics followed by the control design objectives. In
section 4, the LPV model of patients’ MAP response is presented
and LPV gain-scheduling control design is introduced. Section
5 will outline closed-loop results and evaluate the performance
of the proposed LPV controller in the computer simulation envi-
ronment. Finally, section 6 will conclude the paper.
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MAP DRUG RESPONSE MODEL
In the present study, we consider a first-order model with a
time-delay to describe the patient’s MAP response to the infusion
of a vasoactive drug, such as PHP, i.e.
Gp(s) =
∆MAP(s)
U(s)
=
K
T s+1
e−τs, (1)
where ∆MAP stands for the MAP variations in mmHg from its
baseline value, i.e. ∆MAP(t) = MAP(t)−MAPb, U is the drug
infusion rate in ml/h, K denotes the patient’s sensitivity to the
drug, T is the lag time representing the uptake, distribution,
and biotransformation of the drug [21], and τ is the time de-
lay for the drug to reach the circulatory system from the infu-
sion pump. This first-order model seems to properly capture a
patient’s physiological response to the PHP drug injection. Fig-
ure 1 shows a typical MAP response to the step PHP infusion
versus a matched response of the considered model (1). Data is
collected from swine experiments performed at the Resuscitation
Research Laboratory of the University of Texas Medical Branch
(UTMB), Galveston, Texas [10]. Although the proposed model
structure (1) is qualitatively able to represent the characteristics
of the MAP response to the infusion of PHP, the model parame-
ters vary considerably over time due to the variability of patients’
pharmacological response to the vasoactive drug infusion. That
is, the model parameters and delay could vary significantly from
patient-to-patient (inter-patient variability), as well as, for a given
patient over time (intra-patient variability) [21, 22]. Thus, these
variations cause the model parameters K, T , and τ to be time-
varying and a priori unknown.
The designed controller should be able to guarantee stabil-
ity and tracking performance despite these variations. The main
purpose of this work is to design such a controller to automati-
cally regulate the blood pressure to a target value and maintain
hemodynamic stability in hypotensive patients in the presence
of large time-varying delay and model parameter variability by
means of the closed-loop administration of the vasopressor drug,
PHP. The following section, firstly, presents an LPV model for
the patient’s MAP response and then, a delay-dependent output-
feedback control strategy is designed to satisfy the prescribed
closed-loop stability and reference tracking performance.
LPV MODELING AND LPV GAIN-SCHEDULING CON-
TROL DESIGN
In order to apply the linear parameter varying (LPV) con-
trol strategy to the MAP regulation problem, the MAP response
model (1) is formulated as an LPV time-delay model, where the
model parameters are continuously available for the controller as
scheduling parameters. The structure of the closed-loop system
with the LPV controller is shown in Fig. 2.
FIGURE 1. Typical MAP response due to step PHP drug infusion
LPV
Controller
Patient
Parameter
Generation
y∗(t)
+
e(t) u(t) + y
−
K T τ
d(t)
+
FIGURE 2. Closed-loop system structure
MAP Drug Response LPV Modeling
We consider (1) as a first-order model with time-delay to
capture patients’ MAP response dynamics to the PHP infusion
and its equivalent time-domain representation as
T · ˙∆MAP(t)+∆MAP(t) = K ·u(t− τ). (2)
By considering the state variable as x(t) = ∆MAP(t), we can
rewrite the state space representation of the first-order time-
delayed MAP response model as follows
x˙(t) = − 1
T
x(t)+
K
T
u(t− τ),
y(t) = x(t)+do(t),
(3)
where y(t) is the patient’s measured MAP response and do(t) de-
notes output disturbance. In (3), the varying time delay τ = τ(t)
is appearing in the input signal and in order to utilize the pro-
posed time-delay LPV control design framework, we need to
transform the input-delay system into a state-delay LPV repre-
sentation. To this end, we introduce a filtered input signal ua(t)
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as follows
u(s) =
Ω
s+Λ
ua(s), (4)
where Ω and Λ are positive scalars that are selected based on
the bandwidth of the actuators. By considering the augmented
state vector xTa = [ x u xe ]T, and defining the scheduling parame-
ter vector, ρ(t)= [K(t) T (t) τ(t) ]T, the LPV state-delayed state-
space representation of the MAP response dynamics takes the
following form
x˙a(t) = A(ρ(t))xa(t)+Ad(ρ(t))xa(t− τ(t))+B1(ρ(t))w(t)
+B2(ρ(t))u(t)
ya(t) = C2(ρ(t))xa(t)+C2d(ρ(t))xa(t− τ(t))
+D21(ρ(t))w(t),
(5)
where the exogenous disturbance vector w(t) = [ r(t) do(t) ]T
includes the reference command and output disturbance. The
third state is defined for the command tracking purposes, i.e.
x˙e(t) = e(t) = r(t)− y(t) = r(t)− (x(t)+do(t)). Thus, the state
space matrices of the augmented LPV system (5) are obtained as
A(ρ(t)) =
− 1T (t) 0 00 −Λ 0
−1 0 0
 , Ad(ρ(t)) =
0 K(t)T (t) 00 0 0
0 0 0
 ,
B1(ρ(t)) =
0 00 0
1 −1
 ,B2(ρ(t)) =
0Ω
0
 ,
C2(ρ(t)) =
[
1 0 0
]
, D21(ρ(t)) =
[
0 1
]
, (6)
and C2d(ρ(t)) is a zero matrix with compatible dimensions.
Now, by having an appropriate LPV representation of the consid-
ered MAP response model, the proposed LPV gain-scheduling
synthesis is discussed in the following section.
LPV Time-Delay Control Design
Consider the following state-space representation of an LPV
system with a varying state delay
x˙(t) = A(ρ(t))x(t)+Ad(ρ(t))x(t− τ(t))+B1(ρ(t))w(t)
+B2(ρ(t))u(t)
z(t) = C1(ρ(t))x(t)+C1d(ρ(t))x(t− τ(t))+D11(ρ(t))w(t)
+D12(ρ(t))u(t)
y(t) = C2(ρ(t))x(t)+C2d(ρ(t))x(t− τ(t))+D21(ρ(t))w(t),
x(θ) = φ(θ),∀θ ∈ [−τ(ρ(0)), 0],
(7)
where x(t) ∈ Rn is the system state vector, w(t) ∈ Rnw is the
vector of exogenous disturbances with finite energy in the space
L2[0, ∞], u(t) ∈ Rnu is the input vector, z(t) ∈ Rnz is the vec-
tor of outputs to be controlled, y(t) ∈ Rny is the vector of mea-
surable outputs, φ(·) is the initial system condition, and τ is a
differentiable scalar function representing the parameter-varying
time delay. In the present work, the delay is assumed bounded
and the function τ lies in the set T defined as
T := {τ ∈ C (Rs,R) : 0≤ τ(t)≤ τ < ∞,∀t ∈ R+}. (8)
Also, the system’s initial condition function, φ is a given function
in C ([−τ 0 ],Rn). The notation xt(θ) refers to x(t +θ) for θ ∈
[−τ 0 ] where xt is the infinite-dimensional state vector of the
system. The presented state space matrices A(·), Ad(·), B1(·),
B2(·), C1(·), C1d(·), C2(·), C2d(·), D11(·), D12(·), and D21(·)
are known continuous functions of the time-varying parameter
vector ρ(·) ∈F νP , where F νP is the set of allowable parameter
trajectories defined as
F νP , {ρ ∈ C (R+,Rs) : ρ(t) ∈P, |ρ˙i(t)| ≤ νi}, (9)
wherein P is a compact subset of Rs, i.e., the parameter tra-
jectories and parameter variation rates are assumed bounded as
defined. Since the delay is considered to be dependent on the
scheduling parameter vector ρ(t), as a result, the delay bound
should be incorporated into the parameter setF νP . Moreover, in
the present paper, Lyapunov Krasovskii functionals are utilized
to obtain less conservative results, which are valid for bounded
parameter variation rates [16].
In the present work, we use anH∞ design performance spec-
ification for the closed-loop system. The induced L2-gain (or
H∞ norm) of the LPV system (7) from w(t) to z(t) is defined as
‖Tzw‖i,2 = sup
ρ(t)∈FνP
sup
‖w(t)‖2 6=0
‖z(t)‖2
‖w(t)‖2 . (10)
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where Tzw is an operator mapping w(t) to z(t), and ‖w(t)‖2 and
‖z(t)‖2 are the 2-norm of the exogenous input signal and desired
controlled output vector, respectively.
Considering the time-delay LPV system (7) and u(t)≡ 0, the
following theorem provides the sufficient condition that guaran-
tees the asymptotic stability and the specified level of disturbance
rejection performance in theH∞ setting as defined in (10).
Theorem 1. [19] The unforced time-delay LPV system (7) is
asymptotically stable for all τ ∈ T and satisfies the condition
‖z(t)‖2 ≤ γ‖w(t)‖2, if there exists a continuously differentiable
matrix function P : Rs → Sn++, constant matrices Q, R ∈ Sn++,
and a scalar γ > 0 such that the following LMI condition holds
for all ρ ∈F νP .

(1,1) PAd +R PB1 CT1 τA
TR
? Ξ22 0 CT1d τA
T
dR
? ? −γI DT11 τBT1R
? ? ? −γI 0
? ? ? ? −R
≺ 0, (11)
where (1,1) = ATP+PA+
∂P
∂ρi
ρ˙i +Q−R, and Ξ22 = −
(
1−
∂τ
∂ρi
ρ˙i
)
Q−R and and the dependence on the scheduling param-
eter has been dropped for the clarity and simplicity. It should
be noted that the parameter variation rate ρ˙ , enters affinely in
the LMIs in this paper, hence, it is enough to check LMI only at
the vertices of ρ˙ . As a result,
∂P
∂ρi
ρ˙i and
∂τ
∂ρi
ρ˙i are replaced by
∑si=1±
(
νi
∂P
∂ρi
)
and ∑si=1±
(
νi
∂τ
∂ρi
)
, respectively.
The standard matrix inequality characterization presented in
Theorem 1 has multiple product terms of PA and RA, so it is not
suitable to derive the synthesis conditions in which the closed-
loop A matrix includes the unknown terms of the controller to
be designed. To overcome this challenge, a reciprocal variant
of projection Lemma [19] is utilized to derive a relaxed con-
dition. By using this approach, slack variables are introduced
which bring more flexibility in the synthesis problem and lead
to less conservative conditions. The following theorem presents
a relaxed LMI condition using slack variables to guarantee the
asymptotic stability and the specified level of performance in the
H∞ setting given in (10).
Theorem 2. [19] The time-delay LPV system (7) when u ≡ 0
is asymptotically stable for all τ ∈T and satisfies the condition
‖z(t)‖2 ≤ γ‖w(t)‖2, if there exists a continuously differentiable
matrix function P : Rs → Sn++, constant matrices Q, R ∈ Sn++,
matrix functions V1, V2, V3 : Rs → Rn×n, and a scalar γ > 0
such that the following LMI condition holds for all ρ ∈F νP .
−V1−VT1 P−VT2 +V1A −VT3 +V1Ad
? Ψ22 +ATVT2 +V2A R+A
TVT3 +V2Ad
? ? Ξ22 +ATdV
T
3 +V3Ad
? ? ?
? ? ?
? ? ?
V1B1 0 V1 + τR
V2B1 CT1 V2−P
V3B1 CT1d V3
−γI DT11 0
? −γI 0
? ? (−1−2τ)R

≺ 0,
(12)
where Ψ22 =
∂P
∂ρi
ρ˙i+Q−R and Ξ22 has been defined before.
The analysis results presented in Theorem 2 are used to de-
rive a dynamic output feedback controller. In this paper, the time
delay in the system dynamics has been considered to be known
and measurable function of the scheduling parameter ρ . A full-
order dynamic output-feedback controller in the following form
is designed for the time-delay LPV system (7):
x˙k(t) = Ak(ρ)xk(t)+Adk(ρ)xk(t− τ(t))+Bk(ρ)y(t),
u(t) = Ck(ρ)xk(t)+Cdk(ρ)xk(t− τ(t))+Dk(ρ)y(t), (13)
where xk(t) ∈ Rn is the controller state vector and xk(t− τ(t)) ∈
Rn is the delayed state of the controller. Considering the sys-
tem dynamics (7) and the controller (13) the closed-loop system
would be as follows
x˙cl(t) = Acl xcl(t)+Ad,cl xcl(t− τ(t))+Bcl w(t),
z(t) = Ccl xcl(t)+Cd,cl xcl(t− τ(t))+Dcl w(t), (14)
where
Acl =
[
A+B2DkC2 B2Ck
BkC2 Ak
]
,
Ad,cl =
[
Ad +B2DkC2d B2Cdk
BkC2d Adk
]
,Bcl =
[
B1+B2DkD21
BkD21
]
,
Ccl =
[
C1+D12DkC2 D12Ck
]
,
Cd,cl =
[
C1d +D12DkC2d D12Cdk
]
,
Dcl = D11+D12DkD21,
and xcl(t) = [x(t) xk(t) ]T, and the dependence on the schedul-
ing parameter has been dropped for clarity. Now, considering the
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closed-loop system (14), the following result provides sufficient
conditions for the synthesis of a delayed output-feedback con-
troller which guarantees closed-loop asymptotic stability and a
specified level of performance as defined earlier in (10).
Theorem 3. [23] The system (7) is asymptotically stable for
parameters ρ ∈F νP and all delays τ ∈T and satisfy the condi-
tion ||z||2 ≤ γ||w||2 for the closed-loop system (14), if there exists
a continuously differentiable matrix function P˜ : Rs→ S2n++, pa-
rameter dependent matrix functions X,Y : Rs → Sn++, constant
matrices Q˜, R˜ ∈ Sn++, parameter dependent matrices Â, Âd , B̂,
Ĉ, Ĉd , D̂k, three scalars γ > 0, and λ2, λ3 such that the following
LMI condition holds

−2V˜ P˜−λ2V˜+A −λ3V˜+Ad
? Ψ˜22+λ2(A +A T) R˜+λ3A T+λ2Ad
? ? Ξ˜22+λ3(Ad +A Td )
? ? ?
? ? ?
? ? ?
B 0 V˜+ τR˜
λ2B C T λ2V˜− P˜
λ3B C Td λ3V˜
−γI DT 0
? −γI 0
? ? (−1−2τ)R˜

≺ 0,
(15)
with
V˜ =
[
Y I
I X
]
,
A =
[
AY+B2Ĉ A+B2DkC2
Â XA+ B̂C2
]
,
Ad =
[
AdY+B2Ĉd Ad +B2DkC2d
Âd XAd + B̂C2d
]
,
B =
[
B1+B2DkD21
XB1+ B̂D21
]
,
C =
[
C1Y+D12Ĉ C1+D12DkC2
]
,
Cd =
[
C1dY+D12Ĉd C1d +D12DkC2d
]
,
D =
[
D11+D12DkD21
]
,
Ψ˜22 =
[
∑si=1±
(
νi ∂ P˜(ρ)∂ρi
)]
+ Q˜− R˜,
Ξ˜22 = −
[
1−∑si=1±
(
νi ∂τ∂ρi
)]
Q˜− R˜.
(16)
new

X˙+XA+ B̂C2+(?) ?
ÂT+A+B2DkC2 −Y˙+AY+B2Ĉ+(?)
(XB1+ B̂D21)T (B1+B2DkD21)T
C1+D12DkC2 C1Y+D12Ĉ
? ?
? ?
−γI ?
D11+D12DkD21 −γI
≺ 0,
(17)
[
X I
I Y
]
 0, (18)
Once the parameter dependent matrices X, Y, Â, Âd , B̂, Ĉ, Ĉd ,
and D̂k satisfying the mentioned LMI condition (15) have been
obtained, the delayed output-feedback controller matrices can be
computed through the following steps:
1. Determine M and N from the factorization problem
I−XY= NMT, (19)
where the obtained M and N matrices are always square and in-
vertible in the case of computing full-order controllers.
2. Compute the controller matrices by reversing the transforma-
tions defined by
Â = XAY+XB2DkC2Y+NBkC2Y
+XB2CkMT+NAkMT,
Âd = XAdY+XB2DkC2dY+NBkC2dY
+XB2CdkMT+NAdkMT,
B̂ = XB2Dk +NBk,
Ĉ = DkC2Y+CkMT,
Ĉd = DkC2dY+CdkMT.
(20)
3. Finally, the controller matrices are computed in the following
order:
Cdk = (Ĉd−DkC2dY)M−T,
Ck = (Ĉ−DkC2Y)M−T,
Bk = N−1(B̂−XB2Dk),
Adk =−N−1(XAdY+XB2DkC2dY+NBkC2dY
+XB2CdkMT− Âd)M−T,
Ak =−N−1(XAY+XB2DkC2Y+NBkC2Y
+XB2CkMT− Â)M−T.
(21)
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CLOSED-LOOP SIMULATION RESULTS OF MAP REG-
ULATION USING LPV CONTROL
The MAP dynamic regulation problem is formulated in an
LPV framework utilizing the state equations in (5) where the
state-space matrices are as in (6). Moreover, the vector of the
target outputs to be controlled is z = [φxe ξu]T, i.e. C1(ρ(t)) =[
0 0 φ
0 0 0
]
, D12(ρ(t)) = [0, ξ ]T. The matrices C1d(ρ(t)) and
D11(ρ(t)) in (7) are zero matrices with compatible dimensions.
The tracking error which is included in the state xe(t) and the
control effort u(t) are being penalized by the variables φ and
ξ , respectively. The choice of the scalars φ and ξ determines the
relative weighting in the optimization scheme and depends on the
desired performance objectives. The output-feedback controller
is designed to minimize the inducedL2 gain (orH∞ norm) (10)
of the closed-loop LPV system (14). The design objective is
to guarantee the closed-loop stability and minimize the worst
case disturbance amplification over the entire range of model
parameter variations. Theorem 3 is used to design an output-
feedback controller which leads to an infinite-dimensional con-
vex optimization problem with an infinite number of LMIs and
decision variables. To overcome this challenge, we utilize the
gridding approach introduced in [16] to convert the infinite-
dimensional problem to a finite-dimensional convex optimization
problem. In this regard, we choose the functional dependence as
M(ρ(t)) = M0 +
s
∑
i=1
ρi(t)Mi1 +
1
2
s
∑
i=1
ρ2i (t)Mi2 , where M(ρ(t))
represents any of the parameter-dependent matrices appearing in
the LMI condition (15). Finally, gridding the scheduling param-
eter space at appropriate intervals leads to a finite set of LMIs
to be solved for the unknown matrices and γ . The MATLAB R©
toolbox YALMIP is used to solve the introduced optimization
problem [24].
To evaluate the performance of the proposed LPV gain-
scheduling output-feedback control design, collected animal ex-
periment data is used to build a patient’s non-linear MAP re-
sponse model based on (1) where the instantaneous values of the
model parameters K, T , and τ are generated as follows [17].
Sensitivity parameter, K: experiments have confirmed a re-
gressive non-linear relationship between the vasoactive drug
injection and the MAP response through which the patient’s
sensitivity decreases gradually on a constant vasoactive drug
injection. This behavior is captured by the following non-
linear relationship:
akK˙+K = k0exp{−k1i(t)}, (22)
where i(t) is the drug injection and ak, k0, and k1 are uni-
formly distributed random coefficients based on Tab. 1 [25].
For example, a non-responsive patient to the injected va-
soactive drug will be characterized by a low k0 and a high
TABLE 1. Probabilistic distribution of the non-linear patient model
coefficients with uniform distribution U
Parameter Distribution
ak U (500,600)
k0 U (0.1,1)
k1 U (0.002,0.007)
bT U (10−4,3×10−4)
aτ,1 U (5,15)
aτ,2 U (5,15)
bτ,1 U (80,120)
k1.
Lag time, T : This parameter gradually increases with the
injected drug volume and it can be modeled as:
T = sat [Tmin,Tmax] {bT
∫ t
0
i(t)dt}, (23)
where bT is a uniformly distributed random variable which
shows the inclination of the increase and varies based on
Tab. 1.
Infusion delay, τ: Based on the observations, the delay value
has a peak shortly after the drug injection but it decays after-
ward. The following equation is used to describe the delay
behavior:{
aτ,2
...
τ +aτ,1τ¨+ τ˙ = bτ,1 i˙(t)+ i(t), t ≥ ti0 ,
τ = 0, otherwise,
(24)
where the saturation is imposed on the delay value, i.e.
sat[τmin,τmax] τ and the uniformly distributed random variables
aτ,2, aτ,1, and bτ,1 are listed in Tab. 1.
For comparison, we evaluate the proposed controller perfor-
mance against a fixed structure PI controller (see [20]). Given the
following nominal values of the model parameters K = 0.55,T =
150, and τ = 40, the tuned PI controller transfer function is as
follows:
Gc(s) = 3+
0.017
s
, (25)
which is obtained based on the approach proposed in [26] to
meet the prescribed gain and phase margin constraints. In the ab-
sence of disturbances and measurement noise, the tracking pro-
file and the control effort are shown in Fig. 3 where the objec-
tive is to regulate the MAP response to track the commanded
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FIGURE 3. Closed-loop MAP response and control effort of the pro-
posed LPV controller and the fixed structure PI controller with no dis-
turbance and no measurement noise
MAP with minimum overshoot and the settling time and zero
steady-state error. According to this figure, the overshoot of
the closed-loop response remains within the admissible range
and the delay-dependent parameter-varying controller provides
a faster response with less settling time compared to the conven-
tional PI controller. Next, we assume that the closed-loop system
is experiencing both measurement noise and output disturbances.
These disturbances could be the result of medical interventions
and physiological variations due to hemorrhage or other medi-
cations like lactated ringers (LR). Figure 4 is a typical profile
of such disturbances. Considering measurement noise with the
intensity of 10−3, the performance of the LPV and the PI con-
trollers can be seen in Fig. 5. As expected, the proposed LPV
controller outperforms the fixed structure PI controller with re-
spect to the rise time and speed of the response due to its schedul-
ing structure. To conclude, we can observe that the proposed
LPV gain-scheduling control methodology with adaptation for
wide range of patients demonstrates outstanding closed-loop per-
formance in terms of MAP reference tracking and disturbance re-
jection under different scenarios and also is able to maintain the
blood pressure within the allowable range of the reference value
with maximum overshoot under 1% and settling time under 200
seconds.
CONCLUSION AND FUTURE WORK
Automated MAP feedback control for critical patient resus-
citation is addressed in the present paper. In this regard, the
governing dynamics of the MAP response to the vasopressor
drug injection is expressed as an LPV time delayed system and
a delay-dependent LPV output-feedback controller is designed
to guarantee the asymptotic stability and the prescribed perfor-
FIGURE 4. Profile of output disturbances
FIGURE 5. Closed-loop MAP response and control effort of pro-
posed LPV controller against fixed structure PI controller subject to dis-
turbance and measurement noise
mance of the closed-loop system in terms of the induced L2-
norm specification. It is shown that the utilized method and the
choice of the parameter-dependent Lyapunov-Krasovskii func-
tionals have resulted in a direct and also less conservative design
approach, that can also handle the LPV systems with fast-varying
parameters and time delay. Closed-loop simulations using a non-
linear simulation patient model derived from experimental data
demonstrated the controller desirable robustness to model pa-
rameters variations and time-delay while adjusting the set-point
response under disturbances and measurement noise. Future re-
search would focus on developing a new efficient online estima-
tion algorithm to estimate the time-varying model parameters.
8 Copyright c© 2019 by ASME
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